<!DOCTYPE html>
<html lang="">

  <head><script src="/livereload.js?port=1313&mindelay=10&v=2" data-no-instant defer></script>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

    <meta name="author" content="Justin Sybrandt">
    <meta name="description" content="//localhost:1313/">
    <meta name="keywords" content="developer,research,personal,resume,machine,learning">

    <meta property="og:site_name" content="Justin Sybrandt">
    <meta property="og:title" content="
    Inhibition of the DDX3 prevents HIV-1 Tat and cocaine-induced neurotoxicity by
  targeting microglia activation
 - Justin Sybrandt
">
    <meta property="og:description" content="">
    <meta property="og:type" content="website">
    <meta property="og:url" content="//localhost:1313/publications/inhibition_of_ddx3/">
    <meta property="og:image" content="//localhost:1313/">
    <meta name="twitter:card" content="summary">
    <meta name="twitter:site" content="//localhost:1313/publications/inhibition_of_ddx3/">
    <meta name="twitter:image" content="//localhost:1313/">

    <base href="//localhost:1313/publications/inhibition_of_ddx3/">
    <title>
    Inhibition of the DDX3 prevents HIV-1 Tat and cocaine-induced neurotoxicity by
  targeting microglia activation
 - Justin Sybrandt
</title>

    <link rel="canonical" href="//localhost:1313/publications/inhibition_of_ddx3/">
    
    <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.2.0/css/all.css" integrity="sha384-hWVjflwFxL6sNzntih27bfxkr27PmbbK/iSvJ+a4+0owXq79v+lsFkW54bOGbiDQ" crossorigin="anonymous">
    
    <link  rel="stylesheet" href="https://fonts.googleapis.com/css?family=Fira+Mono:400,700">
    <link rel="stylesheet" href="//localhost:1313/css/normalize.min.css">
    <link rel="stylesheet" href="//localhost:1313/css/style.min.css">

    

    

    <link rel="icon" type="image/png" href="//localhost:1313/images/favicon-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="//localhost:1313/images/favicon-16x16.png" sizes="16x16">

    
      <link rel="alternate" href="//localhost:1313/index.xml" type="application/rss+xml" title="Justin Sybrandt">
      <link href="//localhost:1313/index.xml" rel="feed" type="application/rss+xml" title="Justin Sybrandt" />
    



    <meta name="generator" content="Hugo 0.68.3" />
  </head>

  <body class="">
    <main class="wrapper">
      <nav class="navigation">
  <section class="container">
    <a class="navigation-title" href="/">Justin Sybrandt</a>
    <input type="checkbox" id="menu-control"/>
    <label class="menu-mobile  float-right " for="menu-control">
      <span class="btn-mobile  float-right ">&#9776;</span>
      <ul class="navigation-list">
        
          
            <li class="navigation-item  align-center ">
              <a class="navigation-link" href="//localhost:1313/posts">Posts</a>
            </li>
          
            <li class="navigation-item  align-center ">
              <a class="navigation-link" href="//localhost:1313/publications">Publications</a>
            </li>
          
            <li class="navigation-item  align-center ">
              <a class="navigation-link" href="//localhost:1313/updates">Updates</a>
            </li>
          
            <li class="navigation-item  align-center ">
              <a class="navigation-link" href="//localhost:1313/documents/resume.pdf">Resume</a>
            </li>
          
        
        
      </ul>
    </label>
  </section>
</nav>


      <div class="content">
        
  <section class="container post">
  <article class="publication">
    <header>
      <h1 class="title centered">  Inhibition of the DDX3 prevents HIV-1 Tat and cocaine-induced neurotoxicity by
  targeting microglia activation
</h1>
      <h2 class="date centered">November 19, 2019</h2>
      <p class="paper_venue centered"> Journal of Neuroimmune Pharmacology (Accepted, Publication Pending) </p>
      <ul class="author_list centered">
        
          
            <li class="author_elem">Marina Aksenova</li>
          
        
          
            <li class="author_elem author_is_me">Justin Sybrandt</li>
          
        
          
            <li class="author_elem">Biyun Cui</li>
          
        
          
            <li class="author_elem">Vitali Sikirzhytski</li>
          
        
          
            <li class="author_elem">Hao Ji</li>
          
        
          
            <li class="author_elem">Diana Odhiambo</li>
          
        
          
            <li class="author_elem">Mathew Lucius</li>
          
        
          
            <li class="author_elem">Jill R Turner</li>
          
        
          
            <li class="author_elem">Eugenia Broude</li>
          
        
          
            <li class="author_elem">Edsel Pena</li>
          
        
          
            <li class="author_elem">Sofia Lizzaraga</li>
          
        
          
            <li class="author_elem">Jun Zhu</li>
          
        
          
            <li class="author_elem">Ilya Safro</li>
          
        
          
            <li class="author_elem">Michael D Wyatt</li>
          
        
          
            <li class="author_elem">Michael Shtutman</li>
          
        
      </ul>
      <hr>
    
    <ul class="pub_links centered">
      
      <li><a href="https://www.biorxiv.org/content/biorxiv/early/2019/03/29/591438.full-text.pdf">PDF</a></li>
      
    </ul>
    
    </header>
    <h2 id="abstract">Abstract:</h2>
<p>HIV-1 Associated Neurocognitive Disorder (HAND) is commonly seen in HIV-infected
patients. Viral proteins including Tat cause neuronal toxicity and is worsened
by drugs of abuse. To uncover potential targets for anti-HAND therapy, we
employed a literature mining system, MOLIERE. Here, we validated Dead Box RNA
Helicase 3 (DDX3) as a target to treat HAND via a selective DDX3 inhibitor,
RK-33. The combined neurotoxicity of Tat protein and cocaine was blocked by
RK-33 in rat and mouse cortical cultures. Transcriptome analysis showed that
Tat-activated transcripts include makers and regulators of microglial
activation, and RK-33 blocked Tat-induced activation of these mRNAs.  Elevated
production of proinflammatory cytokines was also inhibited by RK-33.  These
findings show that DDX3 contributes to microglial activation triggered by Tat
and cocaine, and DDX3 inhibition shows promise as a therapy for HAND.  Moreover,
DDX3 may contribute to the pathology of other neurodegenerative diseases with
pathological activation of microglia</p>

  </article>
  <br/>
</section>


      </div>
      
        

<script type="text/javascript" async
  src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.4/MathJax.js?config=TeX-MML-AM_CHTML">
</script>
<script type="text/x-mathjax-config">
MathJax.Hub.Config({
  tex2jax: {
    inlineMath: [['$','$'], ['\\(','\\)']],
    displayMath: [['$$','$$'], ['\[','\]']],
    processEscapes: true,
    processEnvironments: true,
    skipTags: ['script', 'noscript', 'style', 'textarea', 'pre','code'],
    TeX: { equationNumbers: { autoNumber: "AMS" },
         extensions: ["AMSmath.js", "AMSsymbols.js"] }
  }
});
</script>


      
    </main>

    

  <script src="//localhost:1313/js/app.js"></script>
  
  </body>
</html>
